Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies

Cancer Risk Associated with Insulin Glargine among Adult Type 2 Diabetes Patients – A Nationwide Cohort Study

Chang Chia-Hsuin
Toh Sengwee
Lin Jou-Wei
Chen Shu-Ting
Kuo Chuei-Wen
Chuang Lee-Ming
Lai Mei-Shu

June 2011

Preclinical and observational studies raise the concern about the safety of insulin glargine in term...

Hyperglycemia and Insulin Usage With the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry. Diabetes;59:1254–1260

Dominique Simon
Beverley Balkau

September 2016

Yang et al. (1) recently reported that insulin usageis associated with a reduced cancer risk. It con...

Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study

But, Anna
De Bruin, Marie L
Bazelier, Marloes T
Hjellvik, Vidar
Andersen, Morten
Auvinen, Anssi
Starup-Linde, Jakob
Schmidt, Marjanka K
Furu, Kari
de Vries, Frank
Karlstad, Øystein
Ekström, Nils
Haukka, Jari

September 2017

AIMS/HYPOTHESIS: The aim of this work was to investigate the relationship between use of certain ins...

Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies

Karlstad, Oystein
Starup-Linde, Jacob
Vestergaard, Peter
Hjellvik, Vidar
Bazelier, Marloes T
Schmidt, Marjanka K
Andersen, Morten
Auvinen, Anssi
Haukka, Jari
Furu, Kari
de Vries, Frank
De Bruin, Marie L

November 2013

BACKGROUND: An association of insulin use and risk of cancer has been reported but evidence is confl...

Insulin glargine and cancer risk in patients with diabetes: a meta-analysis.

Xulei Tang
Lin Yang
Zhiyu He
Jingfang Liu

AIM: The role of insulin glargine as a risk factor for cancer is controversial in human studies. The...

Effect of Long-Acting Insulin Analogs on the Risk of Cancer: A Systematic Review of Observational Studies

Wu, Jennifer W.
Filion, Kristian B.
Azoulay, Laurent
Doll, Margaret K.
Suissa, Samy

June 2018

OBJECTIVE: Observational studies examining the association between long-acting insulin analogs and c...

Insulin analogues and cancer risk: cause for concern or cause célèbre?

Pollak, M
Russell-Jones, D

January 2020

People with diabetes, particularly those with type 2 diabetes, may be at an increased risk of cancer...

Insulin Glargine and Cancer Risk in Patients with Diabetes: A Meta-Analysis

Xulei Tang (110250)
Lin Yang (45852)
Zhiyu He (110255)
Jingfang Liu (31193)

December 2012

<div><h3>Aim</h3><p>The role of insulin glargine as a risk factor for cancer is controversial in hum...

Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: Results from a large population-based follow-up study

Ruiter, Rikje
Visser, Loes
Coebergh, Jan Willem
Herk-Sukel, Myrthe
Haak, H.R.
Geelhoed-Duijvestijn, Nel
Straus, Sabine
Herings, Ron
Stricker, Bruno

January 2012

textabstractAims/hypothesis Several publications suggest an association between certain types of ins...

Doses of Insulin and Its Analogues and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients

Edoardo Mannucci Md
Matteo Monami
Daniela Balzi Md
Barbara Cresci Md
Cecilia Melani Md
Caterina Lamanna Md
Ilaria Bracali Md
Michela Bigiarini Md
Alessandro Barchielli Md
Niccol̀o Marchionni Md
Carlo Maria Rotella

August 2016

OBJECTIVE — Recent epidemiological studies suggested that some insulin analogues could be associated...

Insulin Glargine and Cancer Risk: An Opinion Statement of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy

Edwards, Krystal L.
Riche, Daniel M.
Stroup, Jeffrey S.
Goldman-Levine, Jennifer D.
Padiyara, Rosalyn S.
Cross, L. B.
Kane, Michael P.

September 2010

Diabetes mellitus has reached epidemic proportions worldwide, eliciting extensive research on both t...

Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence

Bronsveld, Heleen K
ter Braak, Bas
Karlstad, Øystein
Vestergaard, Peter
Starup-Linde, Jakob
Bazelier, Marloes T
De Bruin, Marie L
de Boer, Anthonius
Siezen, Christine L E
van de Water, Bob
van der Laan, Jan Willem
Schmidt, Marjanka K

January 2015

INTRODUCTION: Several studies have suggested that anti-diabetic insulin analogue treatment might inc...

Treatment with insulin (analogues) and breast cancer risk in diabetics:a systematic review and meta-analysis of in vitro, animal and human evidence

Bronsveld, Heleen K
Ter Braak, Bas
Karlstad, Øystein
Vestergaard, Peter
Starup-Linde, Jakob
Bazelier, Marloes T
De Bruin, Marie L
de Boer, Anthonius
Siezen, Christine L E
van de Water, Bob
van der Laan, Jan Willem
Schmidt, Marjanka K

January 2015

INTRODUCTION: Several studies have suggested that anti-diabetic insulin analogue treatment might inc...

Cancer risk among insulin users:comparing analogues with human insulin in the CARING five-country cohort study

But, Anna
De Bruin, Marie L.
Bazelier, Marloes T.
Hjellvik, Vidar
Andersen, Morten
Auvinen, Anssi
Starup-Linde, Jakob
Schmidt, Marjanka K.
Furu, Kari
de Vries, Frank
Karlstad, Oystein
Ekstrom, Nils
Haukka, Jari

September 2017

Aims/hypothesis The aim of this work was to investigate the relationship between use of certain insu...

CARING (CAncer Risk and INsulin analoGues):the association of diabetes mellitus and cancer risk with focus on possible determinants - a systematic review and a meta-analysis

Linde, Jakob Starup
Karlstad, Oystein
Eriksen, Stine Aistrup
Vestergaard, Peter
Bronsveld, Heleen K
de Vries, Frank
Andersen, Morten
Auvinen, Anssi
Haukka, Jari
Hjellvik, Vidar
Bazelier, Marloes T
Boer, Anthonius de
Furu, Kari
De Bruin, Marie L

November 2013

Patients suffering from diabetes mellitus (DM) may experience an increased risk of cancer; however, ...

Cancer Risk Associated with Insulin Glargine among Adult Type 2 Diabetes Patients – A Nationwide Cohort Study

Chang Chia-Hsuin
Toh Sengwee
Lin Jou-Wei
Chen Shu-Ting
Kuo Chuei-Wen
Chuang Lee-Ming
Lai Mei-Shu

June 2011

Preclinical and observational studies raise the concern about the safety of insulin glargine in term...

Hyperglycemia and Insulin Usage With the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry. Diabetes;59:1254–1260

Dominique Simon
Beverley Balkau

September 2016

Yang et al. (1) recently reported that insulin usageis associated with a reduced cancer risk. It con...

Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study

But, Anna
De Bruin, Marie L
Bazelier, Marloes T
Hjellvik, Vidar
Andersen, Morten
Auvinen, Anssi
Starup-Linde, Jakob
Schmidt, Marjanka K
Furu, Kari
de Vries, Frank
Karlstad, Øystein
Ekström, Nils
Haukka, Jari

September 2017

AIMS/HYPOTHESIS: The aim of this work was to investigate the relationship between use of certain ins...

Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies

Karlstad, Oystein
Starup-Linde, Jacob
Vestergaard, Peter
Hjellvik, Vidar
Bazelier, Marloes T
Schmidt, Marjanka K
Andersen, Morten
Auvinen, Anssi
Haukka, Jari
Furu, Kari
de Vries, Frank
De Bruin, Marie L

November 2013

BACKGROUND: An association of insulin use and risk of cancer has been reported but evidence is confl...

Insulin glargine and cancer risk in patients with diabetes: a meta-analysis.

Xulei Tang
Lin Yang
Zhiyu He
Jingfang Liu

AIM: The role of insulin glargine as a risk factor for cancer is controversial in human studies. The...

Effect of Long-Acting Insulin Analogs on the Risk of Cancer: A Systematic Review of Observational Studies

Wu, Jennifer W.
Filion, Kristian B.
Azoulay, Laurent
Doll, Margaret K.
Suissa, Samy

June 2018

OBJECTIVE: Observational studies examining the association between long-acting insulin analogs and c...

Insulin analogues and cancer risk: cause for concern or cause célèbre?

Pollak, M
Russell-Jones, D

January 2020

People with diabetes, particularly those with type 2 diabetes, may be at an increased risk of cancer...

Insulin Glargine and Cancer Risk in Patients with Diabetes: A Meta-Analysis

Xulei Tang (110250)
Lin Yang (45852)
Zhiyu He (110255)
Jingfang Liu (31193)

December 2012

<div><h3>Aim</h3><p>The role of insulin glargine as a risk factor for cancer is controversial in hum...

Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: Results from a large population-based follow-up study

Ruiter, Rikje
Visser, Loes
Coebergh, Jan Willem
Herk-Sukel, Myrthe
Haak, H.R.
Geelhoed-Duijvestijn, Nel
Straus, Sabine
Herings, Ron
Stricker, Bruno

January 2012

textabstractAims/hypothesis Several publications suggest an association between certain types of ins...

Doses of Insulin and Its Analogues and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients

Edoardo Mannucci Md
Matteo Monami
Daniela Balzi Md
Barbara Cresci Md
Cecilia Melani Md
Caterina Lamanna Md
Ilaria Bracali Md
Michela Bigiarini Md
Alessandro Barchielli Md
Niccol̀o Marchionni Md
Carlo Maria Rotella

August 2016

OBJECTIVE — Recent epidemiological studies suggested that some insulin analogues could be associated...

Insulin Glargine and Cancer Risk: An Opinion Statement of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy

Edwards, Krystal L.
Riche, Daniel M.
Stroup, Jeffrey S.
Goldman-Levine, Jennifer D.
Padiyara, Rosalyn S.
Cross, L. B.
Kane, Michael P.

September 2010

Diabetes mellitus has reached epidemic proportions worldwide, eliciting extensive research on both t...

Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence

Bronsveld, Heleen K
ter Braak, Bas
Karlstad, Øystein
Vestergaard, Peter
Starup-Linde, Jakob
Bazelier, Marloes T
De Bruin, Marie L
de Boer, Anthonius
Siezen, Christine L E
van de Water, Bob
van der Laan, Jan Willem
Schmidt, Marjanka K

January 2015

INTRODUCTION: Several studies have suggested that anti-diabetic insulin analogue treatment might inc...

Treatment with insulin (analogues) and breast cancer risk in diabetics:a systematic review and meta-analysis of in vitro, animal and human evidence

Bronsveld, Heleen K
Ter Braak, Bas
Karlstad, Øystein
Vestergaard, Peter
Starup-Linde, Jakob
Bazelier, Marloes T
De Bruin, Marie L
de Boer, Anthonius
Siezen, Christine L E
van de Water, Bob
van der Laan, Jan Willem
Schmidt, Marjanka K

January 2015

INTRODUCTION: Several studies have suggested that anti-diabetic insulin analogue treatment might inc...

Cancer risk among insulin users:comparing analogues with human insulin in the CARING five-country cohort study

But, Anna
De Bruin, Marie L.
Bazelier, Marloes T.
Hjellvik, Vidar
Andersen, Morten
Auvinen, Anssi
Starup-Linde, Jakob
Schmidt, Marjanka K.
Furu, Kari
de Vries, Frank
Karlstad, Oystein
Ekstrom, Nils
Haukka, Jari

September 2017

Aims/hypothesis The aim of this work was to investigate the relationship between use of certain insu...

CARING (CAncer Risk and INsulin analoGues):the association of diabetes mellitus and cancer risk with focus on possible determinants - a systematic review and a meta-analysis

Linde, Jakob Starup
Karlstad, Oystein
Eriksen, Stine Aistrup
Vestergaard, Peter
Bronsveld, Heleen K
de Vries, Frank
Andersen, Morten
Auvinen, Anssi
Haukka, Jari
Hjellvik, Vidar
Bazelier, Marloes T
Boer, Anthonius de
Furu, Kari
De Bruin, Marie L

November 2013

Patients suffering from diabetes mellitus (DM) may experience an increased risk of cancer; however, ...

Cancer Risk Associated with Insulin Glargine among Adult Type 2 Diabetes Patients – A Nationwide Cohort Study

Chang Chia-Hsuin
Toh Sengwee
Lin Jou-Wei
Chen Shu-Ting
Kuo Chuei-Wen
Chuang Lee-Ming
Lai Mei-Shu

June 2011

Preclinical and observational studies raise the concern about the safety of insulin glargine in term...

Hyperglycemia and Insulin Usage With the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry. Diabetes;59:1254–1260

Dominique Simon
Beverley Balkau

September 2016

Yang et al. (1) recently reported that insulin usageis associated with a reduced cancer risk. It con...

Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study

But, Anna
De Bruin, Marie L
Bazelier, Marloes T
Hjellvik, Vidar
Andersen, Morten
Auvinen, Anssi
Starup-Linde, Jakob
Schmidt, Marjanka K
Furu, Kari
de Vries, Frank
Karlstad, Øystein
Ekström, Nils
Haukka, Jari

September 2017

AIMS/HYPOTHESIS: The aim of this work was to investigate the relationship between use of certain ins...

Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies

Abstract

Extracted data

Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies

Abstract

Extracted data

Related items

Related items